NEWS & VIEWS

Global private equity and venture capital news and research

Europe

18 November 2011

Global buy-out firms’ UK supermarket deal put on ice

Bidders are expected to wait another month to make secon round offers for British frozen food retailer Iceland, following delays caused by talks with minority shareholder Malcolm Walker over the information to be disclosed to potential buyers.

18 November 2011

WL Ross biggest investor in Northern Rock take-private

pounds3_lrg WL Ross, the private equity fund founded by billionaire investor Wilbur Ross, has been revealed as the largest investor in Richard Branson’s £900m buy-out of nationalised banking giant Northern Rock.

17 November 2011

Swiss biotech company Biocartis raises €71m Series C funding

news_spirogen_molecule_lrg Swiss molecular diagnostic systems start-up Biocartis has raised €71m in Series C financing from a consortium of venture capital investors led by the company’s senior management.

17 November 2011

Belgium’s Gimv posts unrealised losses of €123.8m

decline5sq_lrg Belgium-based private equity firm Gimv reported a seven per cent drop in its net asset value (NAV) per share for the first half of the fiscal year, attributing the negative valuation to the impact from financial market turbulence.

17 November 2011

PAI sells down stake in Danish ingredients maker Chr Hansen

rolling-pin5_sq European private equity firm PAI Partners has further cut its stake in Danish food ingredients company Chr Hansen to 26 per cent, through an accelerated book build offer which will net its Financiere Star 1 vehicle with DKK1.73bn ($310m).

17 November 2011

Apax, TPG accused of Greek telecom ‘bleed-out’

courthouse_lrg UK-based private equity firm Apax Parters and global investment group TPG Capital have been accused of a ‘bleed-out’ of Hellas Telecommunications II, a fraud in which a company’s owners transfer assets to themselves.

17 November 2011

UK’s Oxyrane inks $26.5m investment led by Forbion

Dutch life sciences venture firm Forbion Capital Partners has led a $26.5m Series D financing round for Oxyrane UK, a biopharmaceutical company dedicated to the development of enzyme replacement therapies (ERT) to treat lysosomal storage diseases, a class of more than forty rare inherited diseases.

16 November 2011

Zouk makes €40m investment into cleantech companies

European cleantech investor Zouk Capital has invested €40m into three companies through its latest fund Cleantech Europe II, which closed earlier this year at €230m.

16 November 2011

Hamilton Lane appoints former Dunedin executive

Global asset management firm Hamilton Lane has expanded its London investment team with the addition of Jim Strang as a principal.

16 November 2011

London’s LMS Capital posts NAV drop ahead of wind-down

London-listed private equity firm LMS Capital has posted a four per cent dip in its net asset value (NAV) per share, following an announcement last month that it will wind down its operations amid calls from investors to break the beleaguered firm up.

Page 813 of 1,404« First...102030...811812813814815...820830840...Last »

Legals & Terms of UsePrivacy Policy


AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: WeWork 4001, 1 Fore Street, London, EC2Y 5EJ
Content is © AltAssets 2000-2016